Volume 4, Issue 6, Pages (June 1996)

Slides:



Advertisements
Similar presentations
Volume 44, Issue 3, Pages (March 2016)
Advertisements

Volume 6, Issue 4, Pages (April 1997)
CD4+CD25+ Immunoregulatory T Cells
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1- Related Immune Thrombocytopenia  Michael Nardi, Stephen Tomlinson, M.Alba.
Regulation of Mast Cell Survival by IgE
Volume 6, Issue 2, Pages (February 1997)
Volume 8, Issue 2, Pages (February 1998)
Volume 44, Issue 3, Pages (March 2016)
Kinetic Analysis of High Affinity Forms of Interleukin (IL)-13 Receptors: Suppression of IL-13 Binding by IL-2 Receptor γ Chain  Vladimir A. Kuznetsov,
Volume 13, Issue 4, Pages (October 2000)
Volume 8, Issue 5, Pages (May 1998)
Volume 6, Issue 5, Pages (November 2009)
Volume 23, Issue 1, Pages (July 2005)
High- and Low-Potency Ligands with Similar Affinities for the TCR
Volume 8, Issue 6, Pages (June 1998)
Kenton J. Swartz, Roderick MacKinnon  Neuron 
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Peter A Savage, J.Jay Boniface, Mark M Davis  Immunity 
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 11, Issue 2, Pages (August 1999)
Volume 39, Issue 5, Pages (November 2013)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
The Pathway for Processing Leader-Derived Peptides that Regulate the Maturation and Expression of Qa-1b  Ailin Bai, James Broen, James Forman  Immunity 
Volume 44, Issue 3, Pages (March 2016)
Volume 23, Issue 10, Pages (October 2016)
Volume 1, Issue 7, Pages (June 1998)
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Volume 10, Issue 2, Pages (February 1999)
Volume 21, Issue 3, Pages (September 2004)
Volume 103, Issue 3, Pages (October 2000)
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Jennifer J Kohler, Carolyn R Bertozzi  Chemistry & Biology 
Volume 16, Issue 1, Pages (January 2002)
Zheng Pu, Scott B Lovitch, Elizabeth K Bikoff, Emil R Unanue  Immunity 
Volume 11, Issue 1, Pages (July 1999)
Peter A. Savage, Mark M. Davis  Immunity 
Regulation of Mast Cell Survival by IgE
Yasunori Aizawa, Qing Xiang, Alan M. Lambowitz, Anna Marie Pyle 
Volume 13, Issue 6, Pages (December 2000)
Volume 5, Issue 1, Pages (July 1996)
Volume 86, Issue 6, Pages (June 2004)
Mark P Gray-Keller, Peter B Detwiler  Neuron 
Volume 6, Issue 6, Pages (June 1997)
Volume 32, Issue 2, Pages (February 2010)
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Volume 20, Issue 1, Pages (July 2017)
Kevin M. Marks, Michael Rosinov, Garry P. Nolan  Chemistry & Biology 
αβ T Cell Receptor Ligand-Specific Oligomerization Revisited
Eric A Butz, Michael J Bevan  Immunity 
Formation of a Highly Peptide-Receptive State of Class II MHC
UA62784 Is a Cytotoxic Inhibitor of Microtubules, not CENP-E
Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation
Volume 16, Issue 6, Pages (June 2002)
Volume 11, Issue 4, Pages (February 2001)
Ca2+ Regulation of Gelsolin Activity: Binding and Severing of F-actin
Volume 7, Issue 2, Pages (August 1997)
Interaction of Oxazole Yellow Dyes with DNA Studied with Hybrid Optical Tweezers and Fluorescence Microscopy  C.U. Murade, V. Subramaniam, C. Otto, Martin.
Volume 4, Issue 6, Pages (June 1996)
The Inhibitory Receptor LIR-1 Uses a Common Binding Interaction to Recognize Class I MHC Molecules and the Viral Homolog UL18  Tara L Chapman, Astrid.
Phillip D. Holler, David M. Kranz  Immunity 
Increased TCR Avidity after T Cell Activation
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 9, Issue 2, Pages (August 1998)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Volume 13, Issue 4, Pages (April 2005)
Kenton J. Swartz, Roderick MacKinnon  Neuron 
αβ T Cell Receptor Ligand-Specific Oligomerization Revisited
Presentation transcript:

Volume 4, Issue 6, Pages 565-571 (June 1996) Evidence that a Single Peptide–MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell Response  Yuri Sykulev, Michael Joo, Irina Vturina, Theodore J. Tsomides, Herman N. Eisen  Immunity  Volume 4, Issue 6, Pages 565-571 (June 1996) DOI: 10.1016/S1074-7613(00)80483-5

Figure 1 Peptide Concentrations Required for Half-Maximal Lysis Specific lysis of 51Cr-labeled T2-Ld target cells in the presence of various concentrations of peptides p2Ca (LSPFPFDL), QL9 (QLSPFPFDL), and 127I1-QL9-Y5, the monoiodinated form of QL9-Y5 (QLSPYPFDL). Immunity 1996 4, 565-571DOI: (10.1016/S1074-7613(00)80483-5)

Figure 2 Kinetics of Binding of Monoiodinated Peptide 125I1-QL9-Y5 to Ld on T2-Ld Cells at 37°C (A) The rate of binding of 125I1-QL9-Y5 at a free peptide concentration of 10−10 M. The increase over time in specific binding of the peptide to Ld is shown by the closed circles. The solid line represents the best fit of the experimental points to the theoretical curve described by the single exponential equation for first order kinetics (see Results for details). The insert shows the change in cell-bound radioactivity (cpm) over time in the presence (open circle) and absence (closed square) of a large (10,000-fold molar) excess of the Ld-binding mouse cytomegalovirus peptide pMCMV. The difference represents peptide specifically bound to Ld. (B) Rate of dissociation of 127I1-QL9-Y5 from Ld. Dissociation was monitored by the loss of peptide-stabilized Ld from the surface of brefeldin A–treated T2-Ld cells, measured by the disappearance of FITC fluorescence from antibody-stained cells (see Experimental Procedures). The experimental points (closed square) were fitted to ln (Ft/Fo) = −k−1 • t, where Fo and Ft are the mean fluorescence values on a linear scale at time zero and time t, respectively. The slope of a plot of ln (Ft/Fo) versus t yielded k−1. Immunity 1996 4, 565-571DOI: (10.1016/S1074-7613(00)80483-5)

Figure 3 Distribution of Ld and I1-QL9-Y5–Ld Complexes on T2-Ld Target Cells Percent of the target cells with different levels of Ld expression is shown for the target cell populations that were incubated for 4 hr at 37°C without the CTL and peptide (the initial population) or with the CTL and the peptide at 5 pM (the survived population). The Ld distribution on the lysed cells was determined by difference (see Experimental Procedures). To determine whether the distribution shown (top) changed over 4 hr, target cells expressing low or high Ld levels were sorted, incubated at 37°C for 4 hr, and examined again (with and without restaining) by flow cytometry. No change in distribution in either subset was seen (data not shown). Immunity 1996 4, 565-571DOI: (10.1016/S1074-7613(00)80483-5)